Inspire Medical Systems, Inc.
INSP
$162.16
$3.322.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 28.49% | 32.52% | 34.14% | 41.71% | 53.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.49% | 32.52% | 34.14% | 41.71% | 53.19% |
| Cost of Revenue | 27.35% | 26.89% | 24.35% | 33.48% | 46.07% |
| Gross Profit | 28.70% | 33.58% | 36.06% | 43.32% | 54.57% |
| SG&A Expenses | 17.18% | 21.18% | 25.32% | 32.44% | 40.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.28% | 19.68% | 24.20% | 34.69% | 46.03% |
| Operating Income | 189.60% | 127.04% | 73.35% | 29.48% | 15.38% |
| Income Before Tax | 393.65% | 216.27% | 121.18% | 67.23% | 55.03% |
| Income Tax Expenses | 296.47% | 347.93% | 214.61% | 130.59% | 103.43% |
| Earnings from Continuing Operations | 352.96% | 200.86% | 114.63% | 63.92% | 52.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 352.96% | 200.86% | 114.63% | 63.92% | 52.87% |
| EBIT | 189.60% | 127.04% | 73.35% | 29.48% | 15.38% |
| EBITDA | 213.92% | 138.86% | 79.57% | 32.78% | 18.17% |
| EPS Basic | 345.49% | 199.09% | 114.08% | 65.18% | 54.95% |
| Normalized Basic EPS | 384.87% | 214.23% | 120.44% | 68.35% | 57.00% |
| EPS Diluted | 333.07% | 195.28% | 112.75% | 64.64% | 54.46% |
| Normalized Diluted EPS | 371.00% | 210.34% | 118.92% | 67.64% | 56.35% |
| Average Basic Shares Outstanding | 1.58% | 1.82% | 2.38% | 3.41% | 4.39% |
| Average Diluted Shares Outstanding | 2.96% | 2.54% | 2.46% | 2.89% | 3.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
